{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:27:27Z","timestamp":1790224047643,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ajem.2025.04.011","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T15:58:35Z","timestamp":1744041515000},"page":"71-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Initiation of extended-release buprenorphine in emergency department patients: A retrospective cohort study"],"prefix":"10.1016","volume":"94","author":[{"given":"Louisa","family":"Marion-Bellemare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Samson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Wyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle Carole","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"McGillis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meldon","family":"Kahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajem.2025.04.011_bb0005","series-title":"Opioid- and stimulant-related harms in Canada","author":"Federal, provincial, and territorial Special Advisory Committee on the Epidemic of Opioid Overdoses","year":"2024"},{"key":"10.1016\/j.ajem.2025.04.011_bb0010","article-title":"Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study","volume":"368","author":"Pearce","year":"2020","journal-title":"Bmj-Br Med J"},{"issue":"6","key":"10.1016\/j.ajem.2025.04.011_bb0015","doi-asserted-by":"crossref","first-page":"e374","DOI":"10.1097\/ADM.0000000000001213","article-title":"\u201cReal-world evidence for impact of opioid agonist therapy on nonfatal overdose in patients with opioid use disorder during the COVID-19 pandemic,\u201d (in eng)","volume":"17","author":"Lee","year":"2023","journal-title":"J Addict Med"},{"issue":"2","key":"10.1016\/j.ajem.2025.04.011_bb0020","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/ADM.0000000000000457","article-title":"\u201cBuprenorphine pharmacology review: update on transmucosal and long-acting formulations,\u201d (in eng)","volume":"13","author":"Coe","year":"2019","journal-title":"J Addict Med"},{"issue":"6","key":"10.1016\/j.ajem.2025.04.011_bb0025","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1080\/10826084.2022.2046098","article-title":"\u201cEmergency department utilization patterns in patients with opioid-related emergency department visits,\u201d (in eng)","volume":"57","author":"Shastry","year":"2022","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.ajem.2025.04.011_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2022.108837","article-title":"\u201cEmergency department interventions for opioid use disorder: a synthesis of emerging models,\u201d (in eng)","volume":"141","author":"Thomas","year":"2022","journal-title":"J Subst Abuse Treat"},{"issue":"6","key":"10.1016\/j.ajem.2025.04.011_bb0035","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s11606-017-3993-2","article-title":"\u201cEmergency department-initiated buprenorphine for opioid dependence with continuation in primary care: outcomes during and after intervention,\u201d (in eng)","volume":"32","author":"D\u2019Onofrio","year":"2017","journal-title":"J Gen Intern Med"},{"issue":"5","key":"10.1016\/j.ajem.2025.04.011_bb0040","first-page":"E214","article-title":"Buprenorphine in the emergency department randomized clinical controlled trial of clonidine versus buprenorphine for the treatment of opioid withdrawal","volume":"65","author":"Srivastava","year":"2019","journal-title":"Can Fam Physician"},{"issue":"3","key":"10.1016\/j.ajem.2025.04.011_bb0045","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jemermed.2021.04.007","article-title":"\u201cRetention in treatment after emergency department-initiated buprenorphine,\u201d (in eng)","volume":"61","author":"Jennings","year":"2021","journal-title":"J Emerg Med"},{"issue":"4","key":"10.1016\/j.ajem.2025.04.011_bb0050","doi-asserted-by":"crossref","first-page":"e265","DOI":"10.1097\/ADM.0000000000000922","article-title":"\u201cEvidence of buprenorphine-precipitated withdrawal in persons who use fentanyl,\u201d (in eng)","volume":"16","author":"Varshneya","year":"2022","journal-title":"J Addict Med"},{"issue":"7","key":"10.1016\/j.ajem.2025.04.011_bb0055","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.17128","article-title":"\u201cHigh-dose buprenorphine induction in the emergency department for treatment of opioid use disorder,\u201d (in eng)","volume":"4","author":"Herring","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.ajem.2025.04.011_bb0060","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/ADM.0000000000001202","article-title":"ASAM clinical considerations: buprenorphine treatment of opioid use disorder for individuals using high-potency synthetic opioids","volume":"17","author":"Weimer","year":"2023","journal-title":"J Addict Med"},{"issue":"5","key":"10.1016\/j.ajem.2025.04.011_bb0065","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3109\/00952990.2011.596974","article-title":"Participant characteristics and buprenorphine dose","volume":"37","author":"Hillhouse","year":"2011","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"1","key":"10.1016\/j.ajem.2025.04.011_bb0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/00952990.2022.2106574","article-title":"Open-label, rapid initiation pilot study for extended-release buprenorphine subcutaneous injection","volume":"49","author":"Hassman","year":"2023","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"2","key":"10.1016\/j.ajem.2025.04.011_bb0075","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/02791072.2003.10400007","article-title":"\u201cThe Clinical Opiate Withdrawal Scale (COWS),\u201d (in eng)","volume":"35","author":"Wesson","year":"2003","journal-title":"J Psychoactive Drugs"},{"issue":"5","key":"10.1016\/j.ajem.2025.04.011_bb0080","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/ajad.13193","article-title":"\u201cOpen-label trial of a single-day induction onto buprenorphine extended-release injection for users of heroin and fentanyl,\u201d (in eng)","volume":"30","author":"Mariani","year":"2021","journal-title":"Am J Addict"},{"issue":"12","key":"10.1016\/j.ajem.2025.04.011_bb0085","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1111\/acem.14782","article-title":"\"Early emergency department experience with 7-day extended-release injectable buprenorphine for opioid use disorder,\" (in eng)","volume":"30","author":"D'Onofrio","year":"2023","journal-title":"Acad Emerg Med"},{"issue":"4","key":"10.1016\/j.ajem.2025.04.011_bb0090","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/ADM.0000000000001148","article-title":"Macrodosing\u201c sublingual buprenorphine and extended-release buprenorphine in a hospital setting: 2 case reports,\u201d (in eng)","volume":"17","author":"Kahan","year":"2023","journal-title":"J Addict Med"},{"key":"10.1016\/j.ajem.2025.04.011_bb0095","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"Bmj-Br Med J"},{"issue":"6","key":"10.1016\/j.ajem.2025.04.011_bb0100","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s11606-018-4807-x","article-title":"\u201cEffect of integrating substance use disorder treatment into primary care on inpatient and emergency department utilization,\u201d (in eng)","volume":"34","author":"Wakeman","year":"2019","journal-title":"J Gen Intern Med"},{"issue":"6","key":"10.1016\/j.ajem.2025.04.011_bb0105","doi-asserted-by":"crossref","first-page":"430","DOI":"10.7326\/L18-0685","article-title":"\u201cMedication for opioid use disorder after nonfatal opioid overdose and mortality,\u201d (in eng)","volume":"170","author":"Larochelle","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajem.2025.04.011_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2024.111281","article-title":"\u201cAssociation of buprenorphine retention and subsequent adverse outcomes following non-fatal overdose: an analysis using statewide linked Maryland databases,\u201d (in eng)","volume":"258","author":"Sugarman","year":"2024","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.ajem.2025.04.011_bb0115","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s13643-021-01764-9","article-title":"\u201cRetention in opioid agonist treatment: a rapid review and meta-analysis comparing observational studies and randomized controlled trials,\u201d (in eng)","volume":"10","author":"Klimas","year":"2021","journal-title":"Syst Rev"},{"issue":"4","key":"10.1016\/j.ajem.2025.04.011_bb0120","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/ADM.0000000000000486","article-title":"\u201cImpact of fentanyl use on buprenorphine treatment retention and opioid abstinence,\u201d (in eng)","volume":"13","author":"Wakeman","year":"2019","journal-title":"J Addict Med"},{"issue":"9","key":"10.1016\/j.ajem.2025.04.011_bb0125","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.34540","article-title":"\u201cBuprenorphine dose and time to discontinuation among patients with opioid use disorder in the era of fentanyl,\u201d (in eng)","volume":"6","author":"Chambers","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajem.2025.04.011_bb0130","author":"Statistics Canada"},{"key":"10.1016\/j.ajem.2025.04.011_bb0135","series-title":"Anishininiiwug Ajimoowin Animisiwenan: Mental Health and Substance Use","year":"2024"},{"key":"10.1016\/j.ajem.2025.04.011_bb0140","series-title":"Opioid Use, Related Harms, and Access to Treatment, Among First Nations in Ontario Annual Update, 2013\u20132021","year":"2023"},{"key":"10.1016\/j.ajem.2025.04.011_bb0145","doi-asserted-by":"crossref","first-page":"108807","DOI":"10.1016\/j.jsat.2022.108807","article-title":"\"Follow-up after ED visits for opioid use disorder: do they reduce future overdoses?,\" (in eng)","volume":"142","year":"2022","journal-title":"J Subst Abuse Treat"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073567572500244X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073567572500244X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:29:09Z","timestamp":1762309749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073567572500244X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":29,"alternative-id":["S073567572500244X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2025.04.011","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Initiation of extended-release buprenorphine in emergency department patients: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2025.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}